For the third quarter of 2025, as compared to the same period one year prior, Exponent (EXPO) anticipates: Revenues before reimbursements to be up in the mid-single digits; and, EBITDA1 to be 26.75% to 27.75% of revenues before reimbursements.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EXPO: